Sword Diagnostics, Inc. products

Utilizing our proprietary Sword Swift™ Method Development Process and Sword Swift™ Detection Reagents, our scientists can develop sensitive quantitative assays to measure the amounts of free or bound drug in preclinical or clinical samples with high accuracy and precision.

Sword scientists will use our cell-based assay development expertise to develop a customized method to corroborate the binding specificity of your antibody-drug conjugate (ADC). Our understanding of the molecular basis of cellular growth, proliferation, and differentiation is continually evolving as the genes, proteins, and biochemical pathways critical to these important cellular processes are investigated and understood.

Sword scientists specialize in the development of qualitative or quantitative bioanalytical methods that measure cellular biomolecules active in a specific disease state. Cell-based assays are bioanalytical methods that measure the presence, amount, or activity of biomolecules in cells, cell fractions, nuclear extracts, tissue extracts, or cell extracts. In pharmaceutical drug discovery and development, cell-based assays are critical tools that often provide the initial biochemical evidence that a potential large or small molecule therapeutic is affecting the target or signaling pathway of interest.